This 1 hour module presented by A/Prof Hang Quach, provides an overview of the diagnosis and management of Multiple Myeloma, including the treatment of high risk disease, current therapeutic landscape of treatment available in Australia and the future of novel agents.
Course Description
Course Details
Expiry Date: 2021-03-31
Professions: Specialist
Faculty
Associate Professor Hang Quach
MBBS (Hons) SpecCertOC FRACP FRCPA MD
Haematologist
St Vincent’s Hospital
Principal Fellow, University of Melbourne, VIC
Accreditation
The program is endorsed by the Royal Australian College of Physicians (RACP) and the Royal College of Pathologists of Australasia (RCPA) Committee for Joint College training in Haematology (CJCT) and the Haematology Society of Australia and New Zealand (HSANZ).
Fellows of the RACP and RCPA can claim CPD hours.
Learning Objective(s)
At the end of this module, you will be better able to:
- Explain disease definitions, risk stratification and diagnostic considerations for multiple myeloma
- Describe the basic principles of treatment of multiple myeloma including treatment of high risk disease
- Summarise the current therapeutic landscape of treatment available to patients with multiple myeloma in Australia
- Discuss the evolving treatment paradigm of multiple myeloma in the near future in the context of upcoming novel agents